Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
PHASE4
2000 participants
INTERVENTIONAL
2004-06-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Plenaxis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male ≥ 18 years old with advanced symptomatic prostate cancer for whom LHRH agonist therapy is not appropriate and who refuses surgical castration
* Has at least one of the following:
1. Risk of neurological compromise due to metastases,
2. Ureteral or bladder outlet obstruction due to local encroachment or metastatic disease or
3. Severe bone pain from skeletal metastases persisting on narcotic analgesia
* Patients or their legal representatives must be able to read, understand and sign an informed consent form to participate in the trial.
Exclusion Criteria
* Pediatric patients,
* Patients with known hypersensitivity to any of the components in the abarelix injectable suspension
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PRAECIS Pharmaceuticals Inc.
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerald Riedel, PhD
Role: STUDY_DIRECTOR
PRAECIS Pharmaceuticals Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Millenium Therapeutics & Research - Urology Practice
Birmingham, Alabama, United States
Valley Urologic Associates
Goodyear, Arizona, United States
Foundation for Cancer Research and Education
Phoenix, Arizona, United States
Arizona Urologic Specialists
Tucson, Arizona, United States
Alfred Sidhom, MD, FACS, PC
Anaheim, California, United States
Dr. Chris Threatt
Atherton, California, United States
Hematology-Oncology Group of Fresno
Fresno, California, United States
South Orange County Medical Research Center
Laguna Woods, California, United States
Atlantic Urological Medical Group
Long Beach, California, United States
Paul Neustein, MD. INC
Poway, California, United States
San Diego Urology
San Diego, California, United States
Sherman Oaks Urological Medical Group, Inc.
Sherman Oaks, California, United States
Urology Associates PC
Denver, Colorado, United States
Urologic Associates
Fort Meyers, Florida, United States
Southwest Florida Urologic Associates
Fort Myers, Florida, United States
University of Florida Shands Jacksonville
Jacksonville, Florida, United States
UroSearch
Ocala, Florida, United States
Urology Associates of Ocala, P.A.
Ocala, Florida, United States
South Florida Urology Center Inc
Pembroke Pines, Florida, United States
South Florida Urology Center, Inc.
Pembroke Pines, Florida, United States
Uro-Medix, Inc
Sunrise, Florida, United States
Osvaldo F. Padron MD, FACS
Tampa, Florida, United States
Urological Surgical Services
Tavares, Florida, United States
Osler Medical
West Melbourne, Florida, United States
Urology Associates, P.C.
Marietta, Georgia, United States
Praire Medical Associates, LTD
Chicago, Illinois, United States
Midwest Prostate Urology Health Center
Chicago, Illinois, United States
Urology of Indiana
Indianapolis, Indiana, United States
Unity HealthCare DBA Lafayette Clinic of Urology
Lafayette, Indiana, United States
Heartland Oncology and Hematology
Council Bluffs, Iowa, United States
Private Practice
Emporia, Kansas, United States
KUMC Department of Urology
Kansas City, Kansas, United States
Tri-County Urology
Milford, Massachusetts, United States
Bay State Clinical Trials Inc
Watertown, Massachusetts, United States
Lakeside Urology
Saint Joseph, Michigan, United States
Tewodros Fresseha MD PC
Southfield, Michigan, United States
Midwest Urology
Independence, Missouri, United States
Kansas City Urology Care
Kansas City, Missouri, United States
Quality Clinical Research, LLC
Omaha, Nebraska, United States
Sheldon j. Freedman, MD Ltd
Las Vegas, Nevada, United States
Essex-Hudson Urology
Bloomfield, New Jersey, United States
Hunterdon Urological Associates, PA
Flemington, New Jersey, United States
Northwest Urology Associates
Morristown, New Jersey, United States
Roseland Surgical Suite
Roseland, New Jersey, United States
Urology Healthcare Associates/Rancocas Medical Center
Willingboro, New Jersey, United States
Staten Island Urological Research, PC
Staten Island, New York, United States
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States
American Health Research
Charlotte, North Carolina, United States
Northeast Urology Research
Concord, North Carolina, United States
Washington Urological Associates
Washington, North Carolina, United States
Columbus Urology Research
Columbus, Ohio, United States
Parkhurst Research Organization
Bethany, Oklahoma, United States
Bryn Mawr Urology
Devon, Pennsylvania, United States
Dr. Peter Sinaiko
Langhorne, Pennsylvania, United States
Urology and Urological Oncology
Philadelphia, Pennsylvania, United States
Triangle Urological Group
Pittsburgh, Pennsylvania, United States
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Dr. Greg Echt
Irving, Texas, United States
North West Prostate Institute
Seattle, Washington, United States
Roger D. Fincher, MD
Spokane, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
149-IV-01
Identifier Type: -
Identifier Source: org_study_id